Association of endothelial nitric oxide synthase (NOS3) rs2070744 variant with advanced retinopathy of prematurity: a case–control study and meta-analysis

Abstract Despite advances in neonatal and ophthalmological care, retinopathy of prematurity (ROP) continues to be a leading cause of childhood blindness worldwide. Investigating gene variants associated with vascular responses in ROP may provide valuable insights into its pathogenesis and identify r...

Full description

Saved in:
Bibliographic Details
Main Authors: Aneta Choręziak-Michalak, Dawid Szpecht, Tomasz Woźniak, Anna Chmielarz-Czarnocińska, Patrycja Gazińska, Anna Gotz-Więckowska, Ewa Strauss
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83305-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559639050682368
author Aneta Choręziak-Michalak
Dawid Szpecht
Tomasz Woźniak
Anna Chmielarz-Czarnocińska
Patrycja Gazińska
Anna Gotz-Więckowska
Ewa Strauss
author_facet Aneta Choręziak-Michalak
Dawid Szpecht
Tomasz Woźniak
Anna Chmielarz-Czarnocińska
Patrycja Gazińska
Anna Gotz-Więckowska
Ewa Strauss
author_sort Aneta Choręziak-Michalak
collection DOAJ
description Abstract Despite advances in neonatal and ophthalmological care, retinopathy of prematurity (ROP) continues to be a leading cause of childhood blindness worldwide. Investigating gene variants associated with vascular responses in ROP may provide valuable insights into its pathogenesis and identify risk or protective factors. Nitric oxide (NO) and endothelin-1 (ET-1) play roles in vascular regulation, influencing processes relevant to ROP development. Functional variants of genes encoding endothelial NO sythetase (NOS3 rs1799983, rs2070744), endothelin-1 (EDN1 rs5370), and endothelin receptor A (EDNRA rs5335) may influence ROP development or progression. The results of our study support the role of the rs2070744 variant in ROP. We identified the protective effect of the rs2070744C allele against the development of ROP requiring treatment, also after adjusting for covariates. Meta-analysis including 298 patients and 397 controls confirmed this protective role. The rs2070744CC homozygous genotype exhibited an odds ratio (OR) of 0.42 (adjusted P = 0.036). Additional meta-analysis results for NOS3 rs1799983 are presented, suggesting potential risk in a recessive model. No associations were found between EDN1, EDNRA variants, and ROP. Exploring genetic predispositions in ROP, including vascular regulation genes, can lead to personalized prevention and treatment approaches. Our results need to be replicated in a larger sample of premature infants.
format Article
id doaj-art-138f450cb63c4a94a8c9084c03340ee5
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-138f450cb63c4a94a8c9084c03340ee52025-01-05T12:19:49ZengNature PortfolioScientific Reports2045-23222025-01-0115111310.1038/s41598-024-83305-7Association of endothelial nitric oxide synthase (NOS3) rs2070744 variant with advanced retinopathy of prematurity: a case–control study and meta-analysisAneta Choręziak-Michalak0Dawid Szpecht1Tomasz Woźniak2Anna Chmielarz-Czarnocińska3Patrycja Gazińska4Anna Gotz-Więckowska5Ewa Strauss6Chair and Department of Ophthalmology, Poznan University of Medical SciencesChair and Department of Neonatology, Poznan University of Medical SciencesInstitute of Human Genetics, Polish Academy of SciencesChair and Department of Ophthalmology, Poznan University of Medical SciencesResearch Oncology, Division of Cancer Studies, King’s College LondonChair and Department of Ophthalmology, Poznan University of Medical SciencesInstitute of Human Genetics, Polish Academy of SciencesAbstract Despite advances in neonatal and ophthalmological care, retinopathy of prematurity (ROP) continues to be a leading cause of childhood blindness worldwide. Investigating gene variants associated with vascular responses in ROP may provide valuable insights into its pathogenesis and identify risk or protective factors. Nitric oxide (NO) and endothelin-1 (ET-1) play roles in vascular regulation, influencing processes relevant to ROP development. Functional variants of genes encoding endothelial NO sythetase (NOS3 rs1799983, rs2070744), endothelin-1 (EDN1 rs5370), and endothelin receptor A (EDNRA rs5335) may influence ROP development or progression. The results of our study support the role of the rs2070744 variant in ROP. We identified the protective effect of the rs2070744C allele against the development of ROP requiring treatment, also after adjusting for covariates. Meta-analysis including 298 patients and 397 controls confirmed this protective role. The rs2070744CC homozygous genotype exhibited an odds ratio (OR) of 0.42 (adjusted P = 0.036). Additional meta-analysis results for NOS3 rs1799983 are presented, suggesting potential risk in a recessive model. No associations were found between EDN1, EDNRA variants, and ROP. Exploring genetic predispositions in ROP, including vascular regulation genes, can lead to personalized prevention and treatment approaches. Our results need to be replicated in a larger sample of premature infants.https://doi.org/10.1038/s41598-024-83305-7Meta-analysisNitric oxide synthaseNOS3Retinopathy of prematurityROPNucleotide variants
spellingShingle Aneta Choręziak-Michalak
Dawid Szpecht
Tomasz Woźniak
Anna Chmielarz-Czarnocińska
Patrycja Gazińska
Anna Gotz-Więckowska
Ewa Strauss
Association of endothelial nitric oxide synthase (NOS3) rs2070744 variant with advanced retinopathy of prematurity: a case–control study and meta-analysis
Scientific Reports
Meta-analysis
Nitric oxide synthase
NOS3
Retinopathy of prematurity
ROP
Nucleotide variants
title Association of endothelial nitric oxide synthase (NOS3) rs2070744 variant with advanced retinopathy of prematurity: a case–control study and meta-analysis
title_full Association of endothelial nitric oxide synthase (NOS3) rs2070744 variant with advanced retinopathy of prematurity: a case–control study and meta-analysis
title_fullStr Association of endothelial nitric oxide synthase (NOS3) rs2070744 variant with advanced retinopathy of prematurity: a case–control study and meta-analysis
title_full_unstemmed Association of endothelial nitric oxide synthase (NOS3) rs2070744 variant with advanced retinopathy of prematurity: a case–control study and meta-analysis
title_short Association of endothelial nitric oxide synthase (NOS3) rs2070744 variant with advanced retinopathy of prematurity: a case–control study and meta-analysis
title_sort association of endothelial nitric oxide synthase nos3 rs2070744 variant with advanced retinopathy of prematurity a case control study and meta analysis
topic Meta-analysis
Nitric oxide synthase
NOS3
Retinopathy of prematurity
ROP
Nucleotide variants
url https://doi.org/10.1038/s41598-024-83305-7
work_keys_str_mv AT anetachoreziakmichalak associationofendothelialnitricoxidesynthasenos3rs2070744variantwithadvancedretinopathyofprematurityacasecontrolstudyandmetaanalysis
AT dawidszpecht associationofendothelialnitricoxidesynthasenos3rs2070744variantwithadvancedretinopathyofprematurityacasecontrolstudyandmetaanalysis
AT tomaszwozniak associationofendothelialnitricoxidesynthasenos3rs2070744variantwithadvancedretinopathyofprematurityacasecontrolstudyandmetaanalysis
AT annachmielarzczarnocinska associationofendothelialnitricoxidesynthasenos3rs2070744variantwithadvancedretinopathyofprematurityacasecontrolstudyandmetaanalysis
AT patrycjagazinska associationofendothelialnitricoxidesynthasenos3rs2070744variantwithadvancedretinopathyofprematurityacasecontrolstudyandmetaanalysis
AT annagotzwieckowska associationofendothelialnitricoxidesynthasenos3rs2070744variantwithadvancedretinopathyofprematurityacasecontrolstudyandmetaanalysis
AT ewastrauss associationofendothelialnitricoxidesynthasenos3rs2070744variantwithadvancedretinopathyofprematurityacasecontrolstudyandmetaanalysis